Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04755829Unknown

Breath Test to Predict Breast Cancer and Outcome of Mammography

Role: lead

NCT03451994Completed

Exploratory Study of Volatile Organic Compounds in Alveolar Breath

Role: collaborator

NCT02888366Completed

A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer

Role: lead

NCT02152722Unknown

Breath Test for Biomarkers in Humans Receiving Total Body Irradiation

Role: lead

NCT01397812Unknown

Heartsbreath Test for Heart Transplant Rejection

Role: lead

NCT00639067Completed

Breath Test for Early Detection of Lung Cancer

Role: lead

All 6 trials loaded